Skip to main content
. 2019 Mar 26;11(3):301. doi: 10.3390/v11030301

Figure 4.

Figure 4

The viral load reduction upon treatment with anti-ZIKV IgY: (AC) The infectious viral load was quantified in the brain (A), spleen (B), and liver (C) via a plaque assay. (DF) The viral genomic copy number was quantified in the brain (D), spleen (E), and liver (F) via RT-qPCR. The viral load of the treated mice was compared to the viral control group. * p < 0.05, ** p < 0.01, *** p < 0.005, **** p < 0.0001, and $ is the comparison to the matching ZIKV-specific IgY group.